Novel Oncolytic Agent GLV-1h68 Is Effective Against Malignant Pleural Mesothelioma

Malignant pleural mesothelioma (MPM) is a fatal disease with a median survival of less than 14 months. For the first time, a genetically engineered vaccinia virus is shown to produce efficient infection, replication, and oncolytic effect against MPM. GLV-1h68 is a replication-competent engineered va...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Kelly, Kaitlyn J., Woo, Yanghee, Brader, Peter, Yu, Zhenkun, Riedl, Christopher, Lin, Shu-Fu, Chen, Nanhai, Yu, Yong A., Rusch, Valerie W., Szalay, Aladar A., Fong, Yuman
Format: Artigo
Idioma:Inglês
Publicat: Mary Ann Liebert, Inc. 2008
Matèries:
Scientific Papers
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2940611/
https://ncbi.nlm.nih.gov/pubmed/18754710
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/hum.2008.036
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars